Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-11-17-Speech-1-067"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-11-17"^^xsd:date2
dcterms:Is Part Of	lp_eu:Integrating and strengthening the European research area (2002-2006)2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20031117.6.1-067"2
lpv:hasSubsequent	lp_eu:2003-11-17-Speech-1-0682
lpv:speaker	lp:Elly Plooij-van Gorsel2
lpv:spokenAs	member; Conference of Delegation Chairs (2002-02-07--2004-07-19)3,3 member; ELDR (1999-07-20--2004-07-19)3,3 unknown; Volkspartij voor Vrijheid en Democratie (1999-07-20--2004-07-19)3,3 chair; Delegation for relations with the People's Republic of China (2002-02-07--2004-07-19)3,3 member; Committee on Industry, External Trade, Research and Energy (2002-01-17--2004-07-19)3,3 substitute; ECON (2002-01-17--2004-07-19)3,3
lpv:translated text	"Mr President, Commissioner, ladies and gentlemen, this debate is not about whether the European Union should permit research using stem cells and embryos. The position varies from one Member State to another and is a matter of subsidiarity, and we in this Parliament have no say whatever in the matter. We should concentrate on the question of whether the stem cell research that is carried out in EU Member States can be financed with funds from the sixth framework programme. In September 2002, this question was also the topic of negotiation between the Commission, Council and Parliament during the debates about the sixth framework programme. At that time, a compromise was reached, and Parliament voted in favour of it. Our position is therefore unambiguous. Thanks to the compromise, it is possible to finance stem cell research with Community funds in those Member States where such research is permitted. A moratorium has subsequently been imposed at the request of a few Member States; with effect from September 2003, European funding of stem cell research is frozen until the Commission tables a new proposal. This Commission proposal is now before us and I urge my fellow MEPs to give it their backing. After all, it is in line with our position of September 2002 and therefore provides consistency. Mr Liese, the rapporteur, has attempted to undermine Parliament's position in a scandalous manner by, during the discussion in the Committee on Industry, External Trade, Research and Energy, tabling extremely restrictive amendments, which make embryonic research in the European Union virtually impossible. Indeed, not only has he introduced an end date, after which stem cell lines created before that date cannot be used, he has also limited the proposal's scope by permitting research only on existing stem cell lines. He has ruled out the development of new stem cell lines from supernumerary embryos, while it is in this very field that the EU should gain research experience. Fortunately, the Committee on Industry, External Trade, Research and Energy has opted for consistency and has taken a stand against most of Mr Liese's amendments."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph